ClinicalTrials.gg
TerminatedNCT07202702Updated Oct 22, 2026Results posted

Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task

An interventional study of tDCS in Motor Activity, sponsored by Indiana University. Terminated at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Indiana University · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
Interim study results were not favorable to continue with further enrollment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Apr 2025, registered Aug 2025).
Updated Oct 22, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Motor Activity by Indiana University — 3 open to participants now, 3 under way, none of them phase 3. Motor Activity · Indiana University.

Enrollment
9th of 13
40 · median 60
Started
2025
with 1 other
No phase
11 of 14
3 open now
Registered
13th of 14
by date

Among the 14 studies in Motor Activity by Indiana University, this one is the 9th largest by enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2025, is one of 11 with no phase, and was the 13th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

3 of the 14 studies in Motor Activity by Indiana University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Motor Activity by Indiana University, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether "transcranial direct current stimulation" (tDCS) is effective in enhancing learning of complex motor tasks of precision and accuracy that require the simultaneous coordination of both hands. The study will utilize a between-subjects, SHAM controlled design. Subjects will be randomly selected to receive either SHAM (n=26) or a-tDCS (n=26) stimulation and will be blinded to their condition throughout testing. Subjects will complete a total of two testing sessions, separated by \~24 hours. Both sessions will have the subject play the videogame "Guitar Hero", with a single song done for several trials as pre- and post-assessments. The first session will contain a 20-minute practice/stimulation block where subjects practice the guitar task while receiving either "active" or "inactive" stimulation of the motor cortex. The first session will last approximately 75 to 90 minutes whereas the second session will last approximately 15 to 20 minutes.

03

Conditions studied

  • Motor Activity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between ages 18 and 45 years old (to avoid any changes in the developing brain, or with aging).
  • Answer 'no' to questions 2 through 16 on the tDCS checklist as these factors can increase likelihood of adverse events with tDCS
  • No neurological damage, disease, or dysfunction (nerve damage, chronic pain disorders, diabetic neuropathy) that affect the upper limbs.
  • No significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study

Exclusion criteria

Exclusion Criteria:

    • Currently prescribed and taking stimulant medication (Adderall, Ritalin, Vyvanse, etc.)

      • Consumption of over-the-counter stimulants such as caffeine or nicotine (coffee, soda, supplements, energy drinks, tobacco products, or other nicotine containing products such as gum, vape pens, etc...) 12 hours prior to entering the lab on the day of testing as this can directly affect cortical excitability. If a subject takes any of these substances 12 hours prior to session 1 they will be asked to reschedule for a later date.
      • Have played a real stringed instrument in the last 12 months (e.g. guitar, bass, violin)
      • Have played the videogame "Guitar Hero" on a traditional guitar controller in the last 12 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    tDCS

    This group will receive 20 minutes of 1 mA tDCS stimulation to the motor cortex while playing the videogame. The total session duration will last approximately 30 minutes and there will be a 30 minutes retention session 24 hours later.

    Device: tDCS

  • Placebo comparator
    SHAM

    This group will receive 30 seconds of 1 mA tDCS stimulation to the motor cortex and then it will shut off, effectively serving as a control, while subjects play the videogame for 20 minutes. The total session duration will last approximately 30 minutes and there will be a 30 minutes retention session 24 hours later.

    Device: tDCS

Interventions

  • DevicetDCS

    Applying tDCS to determine if it facilitates learning of a video game task

06

What researchers measure

Primary outcomes

  1. Improvement in a Video Game

    To determine whether a-tDCS influences motor skill acquisition of a dexterous video game task by measuring the outcome of videogame performance (number of notes played) with and without a-tDCS. The number of correct notes played is the outcome measure- where the greater the number, the better the outcome or performance. All subjects were expected to increase in performance, but the hypothesis was that the performance in the tDCS group would be greater than in sham.

    Time frame: 20 minutes- change in number of notes played t2-t1

Secondary outcomes

  1. Retention and Learning

    Learning will be measured within-groups by examining retention, or the outcome of video game performance (number of notes played) between the first and second sessions. The number of notes successfully played, where more notes equated to improved outcomes or performance.

    Time frame: 24 hours difference in notes between t2-t1

07

Results

Posted Oct 22, 2026

Participant flow

Participant flow — Overall Study
MilestonetDCSSHAM
Started2020
Completed2020
Not completed00

Outcome measures

PrimaryImprovement in a Video Game

To determine whether a-tDCS influences motor skill acquisition of a dexterous video game task by measuring the outcome of videogame performance (number of notes played) with and without a-tDCS. The number of correct notes played is the outcome measure- where the greater the number, the better the outcome or performance. All subjects were expected to increase in performance, but the hypothesis was that the performance in the tDCS group would be greater than in sham.

Time frame:
20 minutes- change in number of notes played t2-t1
Reported as:
Mean · change in number of notes played
Improvement in a Video Game
change in number of notes playedtDCSSHAM
Improvement in a Video Game15.72 ± 7.5915.5 ± 10.73
SecondaryRetention and Learning

Learning will be measured within-groups by examining retention, or the outcome of video game performance (number of notes played) between the first and second sessions. The number of notes successfully played, where more notes equated to improved outcomes or performance.

Time frame:
24 hours difference in notes between t2-t1
Reported as:
Mean · change in number of notes played
Retention and Learning
change in number of notes playedtDCSSHAM
Retention and Learning3.07 ± 3.162.38 ± 2.91

Adverse events

Collected over up to 24 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
tDCS0/20 (0%)0/20 (0%)0/20 (0%)
SHAM0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)tDCSSHAMTotal
<=18 years000
Between 18 and 65 years202040
>=65 years000
Age, Continuous
Age, Continuous(years)tDCSSHAMTotal
Mean22.8 ± 4.0321.5 ± 1.4922 ± 3.1
Sex: Female, Male
Sex: Female, Male(Participants)tDCSSHAMTotal
Female9918
Male111122
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)tDCSSHAMTotal
Count of participants——0
08

Study locations

1 site
  • National Institute for Fitness and Sport
    Indianapolis, Indiana 46202, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2025 to primary completion in Dec 2025, 7 months.

Results were first posted in Oct 2026, 10 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2025
First posted
Oct 2, 2025
StartActual
Apr 4, 2025
Primary completionActual
Dec 3, 2025
CompletionActual
Dec 3, 2025
Results first posted
Oct 22, 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Why stopped
Interim study results were not favorable to continue with further enrollment
Oct 22, 2026
Results
Results posted
posted Oct 22, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedImprovement in a video gameVideo GameTime frame: 1 year → 20 minutes- change in number of notes played t2-t1
Oct 22, 2026
Documents
Secondary outcomes
1 time frame changed, 1 description edited
What changed in the outcomes
  • Time frameRetention and Learning1 Year → 24 hours difference in notes between t2-t1
  • DescriptionRetention and Learning: how it is measured was reworded
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Why stopped Interim study results were not favorable to continue with further enrollment
    Results posted
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedImprovement in a video gameVideo GameTime frame: 1 year → 20 minutes- change in number of notes played t2-t1
    Secondary outcomes 1 time frame changed, 1 description edited
    What changed in the outcomes
    • Time frameRetention and Learning1 Year → 24 hours difference in notes between t2-t1
    • DescriptionRetention and Learning: how it is measured was reworded
    + 3 other changes: index terms, verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07202702
Lead sponsor
Indiana University
Responsible party
Zachary Riley (Associate Professor, Indiana University) — Principal investigator
First posted
Oct 2, 2025
Start date
Apr 4, 2025
Primary completion
Dec 3, 2025
Completion
Dec 3, 2025
Results posted
Oct 22, 2026
Last update
Oct 22, 2026

Study contacts

Zachary Riley
principal investigator · Indiana University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion